Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Kekkaku : [Tuberculosis]|October 20, 2015
[DRUG-INDUCED LIVER INJURY AND PYRAZINAMIDE USE]Nobuyuki Horita, Naoki MiyazawaScientific Reports|March 3, 2018
Antimicrobial mechanisms due to hyperpolarisation induced by nanoporous AuNaoki Miyazawa, Masataka Hakamada, Mamoru MabuchiTranslational Lung Cancer Research|March 26, 2015
Pre-operative chemotherapy for non-small cell lung carcinomaNobuyuki Horita, Tetsukan Woo, Naoki Miyazawa, et al.Scientific Reports|February 2, 2019
Electronic origin of antimicrobial activity owing to surface effectNaoki Miyazawa, Susumu Sakakibara, Masataka Hakamada, et al.Kekkaku : [Tuberculosis]|August 1, 2013
[Prognosis of patients with tuberculosis]Nobuyuki Horita, Naoki Miyazawa, Takashi Yoshiyama, et al.Respirology (Carlton, Vic.)|August 4, 2015
Long-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysisNobuyuki Horita, Naoki Miyazawa, Koji Tomaru, et al.Scientific Reports|June 14, 2020
Antibacterial activity of ultrathin platinum islands on flat gold against Escherichia coliMasataka Hakamada, Susumu Sakakibara, Naoki Miyazawa, et al.Respiratory Investigation|May 24, 2014
Three cases of mesalazine-induced pneumonitis with eosinophiliaMiyo Inoue, Nobuyuki Horita, Naoko Kimura, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|February 19, 2005
[Usefulness of urinary antigen and sputum Gram stain for rapid diagnosis of pneumococcal respiratory infections]Yuji Watanuki, Hiroshi Takahashi, Takashi Ogura, et al.Internal Medicine (Tokyo, Japan)|September 16, 2015
Currently Used Low-Dose Pyrazinamide Does Not Increase Liver-Injury in the First Two Months of Tuberculosis TreatmentNobuyuki Horita, Naoki Miyazawa, Takashi Yoshiyama, et al.Pageof 7